Skip to content
Screener

Pacira BioSciences, Inc. PCRX Business Segments — Legal settlement

Similar metrics at other companies

Douglas Elliman logo
DOUGOne Reportable Segment — Antitrust litigation settlement expense
$0—
Altria Group logo
MOSmokeable Products — Litigation Settlement, Loss
$785M-1.8%
Mastercard logo
MALegal settlement
$0-100%
Cencora logo
CORLegal settlement
$13.86M+20.3%
Applied Materials logo
AMATSemiconductor Systems — Legal settlement
$253M—
Applied Materials logo
AMATApplied Global Services — Legal settlement
$0—

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$997.34M-11.9%
Enterprise value$1.26B+6.9%
P/E194.1×—
P/S1.4×-0.2×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%—
Net margin0.7%—
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%—
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LitigationSettlementLoss.

The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028871
Line itemThree Months Ended March 31, 20262025
Contingent consideration gains$(2,277)$(2,675)
Acquisition-related expenses—1,511
Legal settlement—7,000
Other—351
Total other operating (gains) expenses, net$(2,277)$6,187

Item 1. FINANCIAL STATEMENTS (Unaudited)

FAQ

What is Pacira BioSciences, Inc.'s business segments — legal settlement?
Pacira BioSciences, Inc. (PCRX) reported business segments — legal settlement of $0 in Q1 2026.
How has Pacira BioSciences, Inc.'s business segments — legal settlement changed year-over-year?
Pacira BioSciences, Inc.'s business segments — legal settlement decreased by 100.0% year-over-year, from $7M to $0.
What does business segments — legal settlement mean?
Captures the financial impact of legal settlements or litigation-related costs specifically attributed to the operations of the reportable segment. This metric highlights non-recurring financial risks and potential liabilities arising from legal disputes.

Ask your AI about Pacira BioSciences, Inc.'s business segments — legal settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude